iShares Biotechnology ETF (NYSE Biotechnology) against iShares U.S. Healthcare ETF (Russell 1000 Health Care RIC 22.5/45 Capped) — fees, long-horizon total returns, holdings overlap, and sector tilt, side by side.
Daily bar history for this pair isn’t loaded yet — returns will appear once the nightly ingest covers both funds.
| IBB | IYH | |
|---|---|---|
| Name | iShares Biotechnology ETF | iShares U.S. Healthcare ETF |
| Category | Health | Health |
| Style | Passive | Passive |
| Expense ratio | 0.45% | — |
| Assets (AUM) | $9.2B | $3.6B |
| Dividend yield | 0.22% | 1.17% |
| Avg volume (3-mo) | 1.6M | 799K |
| Inception | February 5, 2001 | June 12, 2000 |
| Benchmark proxy | S&P 500 | S&P 500 |
Expense ratios verified against issuer fact sheets. Dividend yield is trailing 12-month distributions divided by price, as reported by the fund data provider.
| Shared holding | IBB | IYH | MIN |
|---|---|---|---|
| AMGNAmgen Inc | 8.51% | 3.43% | 3.43% |
| GILDGilead Sciences Inc | 7.21% | 2.67% | 2.67% |
Sum of min(weight in each fund) across shared tickers — the standard fund-overlap measure. Computed on the top 25 holdings each fund reports, so it is a lower bound; the coverage figures show how much of each fund those top holdings represent.